Eli Lilly, Obesity Drug Manufacturer, Comes to Pennsylvania
The company plans a major manufacturing and distribution push as demand for obesity medications rises, officials said.
- On Thursday, Eli Lilly broke ground on a $3.5 billion manufacturing facility in the Lehigh Valley to produce next-generation injectable medicines, including treatments for obesity and type two diabetes.
- Governor Josh Shapiro and U.S. Senator Dave McCormick praised the investment as a "major win" for Pennsylvania, cementing the Commonwealth's position as a leader in life sciences and innovation.
- The site will bring 850 high-paying jobs to the region, and Lilly also plans to provide up to $1 million over five years to the Upper Macungie Township Community Fund for community health programs.
- Lilly chair and CEO David A. Ricks said the facility will produce retatrutide, an investigational medicine in phase three trials, potentially helping millions with obesity, type two diabetes, and cardiovascular disease.
- Pennsylvania's life sciences industry comprises approximately 3,900 companies employing more than 110,000 people and contributing $73 billion to the state economy, with officials describing the facility as a "generational project.
18 Articles
18 Articles
Eli Lilly to open new facility in Pennsylvania, creating nearly 3,000 new jobs
PENNSYLVANIA U.s (WTAJ)---Pharmaceutical company Eli Lilly officially broke ground on its new manufacturing facility in Pennsylvania yesterday, with the project already ahead of schedule. While construction is still in its early stages, the facility is expected to bring thousands of jobs to the state. Rick Seipp, president of Value Drug Company in Duncansville, says the [...]
Eli Lilly Breaks Ground on $3.5B Lehigh Valley Manufacturing Campus
Eli Lilly and Company broke ground on a $3.5 billion manufacturing facility in Pennsylvania’s Lehigh Valley. The site is one of 10 new U.S. manufacturing sites announced since 2020, and one of four dedicated to injectable medicines and devices. Part of the company’s $50 billion push to expand medicine production in the U.S., the Lehigh ...
Coverage Details
Bias Distribution
- 89% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
